Publications by authors named "Emily M Sandhaus"
Ann Thorac Surg
August 2021
Article Synopsis
- The study explores the use of hepatitis C-positive (HCV+) organs for heart/kidney transplants, particularly benefiting patients with both heart failure and kidney issues, starting in 2017.
- Researchers analyzed data from 39 heart/kidney transplants between 2012 and 2019, comparing outcomes between patients receiving HCV+ organs and those receiving HCV-negative (HCV-) organs.
- Results showed that while HCV+ recipients had slightly higher creatinine levels shortly after the transplant, their overall survival rates and organ function after one year were similar to those of HCV- recipients, indicating that HCV+ organs can be safely utilized to reduce waitlist times.
